Streamline Health Solutions (STRM)
(Delayed Data from NSDQ)
$0.18 USD
0.00 (-1.34%)
Updated Sep 18, 2024 04:00 PM ET
After-Market: $0.19 +0.01 (7.77%) 7:58 PM ET
NA Value
NA Growth NA Momentum NA VGMIncome Statements
Fiscal Year end for Streamline Health Solutions, Inc falls in the month of January .
All items in Millions except EPS data.
1/31/24 | 1/31/23 | 1/31/22 | 1/31/21 | 1/31/20 | |
---|---|---|---|---|---|
Sales | 23 | 25 | 17 | 11 | 21 |
Cost Of Goods | 11 | 13 | 9 | 6 | 7 |
Gross Profit | 12 | 11 | 9 | 6 | 13 |
Selling & Adminstrative & Depr. & Amort Expenses | 31 | 22 | 20 | 12 | 15 |
Income After Depreciation & Amortization | -20 | -11 | -11 | -6 | -2 |
Non-Operating Income | 2 | 0 | 4 | 0 | 0 |
Interest Expense | 1 | 1 | 0 | 0 | 0 |
Pretax Income | -19 | -11 | -7 | -6 | -3 |
Income Taxes | 0 | 0 | 0 | -1 | 0 |
Minority Interest | 0 | 0 | 0 | 0 | 0 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | -19 | -11 | -7 | -5 | -3 |
Extras & Discontinued Operations | 0 | 0 | 0 | 5 | 0 |
Net Income (GAAP) | -19 | -11 | -7 | 0 | -3 |
Depreciation Footnote | 1/31/24 | 1/31/23 | 1/31/22 | 1/31/21 | 1/31/20 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | -6 | -7 | -7 | -3 | 0 |
Depreciation & Amortization (Cash Flow) | 14 | 4 | 4 | 3 | 3 |
Income After Depreciation & Amortization | -20 | -11 | -11 | -6 | -2 |
Earnings Per Share Data | 1/31/24 | 1/31/23 | 1/31/22 | 1/31/21 | 1/31/20 |
---|---|---|---|---|---|
Average Shares | 56.51 | 49.33 | 42.82 | 30.64 | 22.74 |
Diluted EPS Before Non-Recurring Items | -0.14 | -0.23 | -0.16 | -0.16 | -0.04 |
Diluted Net EPS (GAAP) | -0.33 | -0.23 | -0.15 | 0.01 | -0.13 |
Fiscal Year end for Streamline Health Solutions, Inc falls in the month of January .
All items in Millions except EPS data.
7/31/24 | 4/30/24 | 1/31/24 | 10/31/23 | 7/31/23 | |
---|---|---|---|---|---|
Sales | 4.48 | 4.33 | 5.36 | 6.13 | 5.77 |
Cost Of Goods | 2.38 | 2.28 | 2.44 | 2.88 | 2.95 |
Gross Profit | 2.10 | 2.05 | 2.92 | 3.26 | 2.82 |
SG&A, R&D, and Dept/Amort Expenses | 4.31 | 4.30 | 5.02 | 16.20 | 5.43 |
Income After SG&A, R&D, and Dept/Amort Expenses | -2.21 | -2.25 | -2.10 | -12.94 | -2.61 |
Non-Operating Income | -0.09 | -0.02 | 0.04 | 1.18 | 0.36 |
Interest Expense | 0.50 | 0.47 | 0.29 | 0.27 | 0.27 |
Pretax Income | -2.80 | -2.74 | -1.36 | -12.03 | -2.51 |
Income Taxes | 0.00 | 0.00 | 0.01 | -0.12 | 0.01 |
Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investment Gains/Losses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | -2.80 | -2.74 | -1.37 | -11.91 | -2.52 |
Extras & Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | -2.80 | -2.74 | -1.37 | -11.91 | -2.52 |
Earnings Per Share Data | 7/31/24 | 4/30/24 | 1/31/24 | 10/31/23 | 7/31/23 |
---|---|---|---|---|---|
Average Shares | 60.11 | 58.22 | 57.00 | 56.71 | 56.36 |
Diluted EPS Before Non-Recurring Items | -0.05 | -0.05 | -0.02 | -0.02 | -0.04 |
Diluted Net EPS (GAAP) | -0.05 | -0.05 | -0.03 | -0.21 | -0.04 |